To investigate which STAT pathway regulates IFI44L expression, we treated SLE monocytes with STAT1, STAT3, and STAT5 pathway inhibitors and blank solvent, respectively, along with stimulation from IFN-α. Here, STAT3 is linked to systemic lupus erythematosus.